AUY922 effectively overcomes MET- And AXL-mediated resistance to EGFR-TKI in lung cancer cells

MLA

Bivona, Trever, et al. AUY922 Effectively Overcomes MET- And AXL-Mediated Resistance to EGFR-TKI in Lung Cancer Cells. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1367639380&authtype=sso&custid=ns315887.

APA

Bivona, T., Bivona, T., Choi, Y., Kim, S., So, K., Baek, I., Kim, W., Choi, S., Lee, J., Bivona, T., Rho, J., & Choi, C. (2015). AUY922 effectively overcomes MET- And AXL-mediated resistance to EGFR-TKI in lung cancer cells.

Chicago

Bivona, Trever, Trever Bivona, Yj Choi, Sy Kim, Ks So, Ij Baek, Ws Kim, et al. 2015. “AUY922 Effectively Overcomes MET- And AXL-Mediated Resistance to EGFR-TKI in Lung Cancer Cells.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1367639380&authtype=sso&custid=ns315887.